Moxifloxacin Prophylaxis Against MDR TB, New York, New York, USA

Emerging Infectious Diseases - United States
doi 10.3201/eid2103.141313
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Centers for Disease Control and Prevention (CDC)